fanta.bio Sample: CNhs11253
19316 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| SCML2 SRX644728 | 293 Kidney | 1834 / 17950 (10.2%) | 590 / 179500 (0.3%) | −324.0 | −324.0 | 31.08 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1998 / 17950 (11.1%) | 704 / 179500 (0.4%) | −324.0 | −324.0 | 28.38 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2840 / 17950 (15.8%) | 1060 / 179500 (0.6%) | −324.0 | −324.0 | 26.79 |
| FOXP1 SRX736067 | LNCAP Prostate | 2486 / 17950 (13.8%) | 941 / 179500 (0.5%) | −324.0 | −324.0 | 26.42 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2737 / 17950 (15.2%) | 1052 / 179500 (0.6%) | −324.0 | −324.0 | 26.02 |
| HIF1A SRX11007095 | HK-2 Kidney | 2087 / 17950 (11.6%) | 1013 / 179500 (0.6%) | −324.0 | −324.0 | 20.60 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 978 / 17950 (5.4%) | 500 / 179500 (0.3%) | −324.0 | −324.0 | 19.56 |
| MYH11 SRX265221 | ME-1 Blood | 1019 / 17950 (5.7%) | 569 / 179500 (0.3%) | −324.0 | −324.0 | 17.91 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1398 / 17950 (7.8%) | 893 / 179500 (0.5%) | −324.0 | −324.0 | 15.66 |
| MED1 SRX9419945 | BT-474 Breast | 3580 / 17950 (19.9%) | 3014 / 179500 (1.7%) | −324.0 | −324.0 | 11.88 |
| MED1 SRX9419944 | BT-474 Breast | 3444 / 17950 (19.2%) | 2959 / 179500 (1.6%) | −324.0 | −324.0 | 11.64 |
| MED1 SRX9419946 | BT-474 Breast | 3609 / 17950 (20.1%) | 3186 / 179500 (1.8%) | −324.0 | −324.0 | 11.33 |
| EZH2 SRX2146136 | LNCAP Prostate | 9002 / 17950 (50.2%) | 8015 / 179500 (4.5%) | −324.0 | −324.0 | 11.23 |
| BRD4 SRX9419938 | BT-474 Breast | 3542 / 17950 (19.7%) | 3184 / 179500 (1.8%) | −324.0 | −324.0 | 11.12 |
| BRD4 SRX9419936 | BT-474 Breast | 3551 / 17950 (19.8%) | 3198 / 179500 (1.8%) | −324.0 | −324.0 | 11.10 |
| MED1 SRX9419947 | BT-474 Breast | 3465 / 17950 (19.3%) | 3162 / 179500 (1.8%) | −324.0 | −324.0 | 10.96 |
| BRD4 SRX9419935 | BT-474 Breast | 3380 / 17950 (18.8%) | 3104 / 179500 (1.7%) | −324.0 | −324.0 | 10.89 |
| BRD4 SRX9419937 | BT-474 Breast | 3384 / 17950 (18.9%) | 3114 / 179500 (1.7%) | −324.0 | −324.0 | 10.87 |
| BRD4 SRX736201 | 90-8TL Neural | 5998 / 17950 (33.4%) | 7007 / 179500 (3.9%) | −324.0 | −324.0 | 8.56 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1971 / 17950 (11.0%) | 2830 / 179500 (1.6%) | −324.0 | −324.0 | 6.96 |
| PBX4 SRX2731658 | PC-3 Prostate | 864 / 17950 (4.8%) | 28335 / 179500 (15.8%) | −324.0 | −324.0 | 0.30 |
| FOS SRX150478 | MCF 10A Breast | 569 / 17950 (3.2%) | 21687 / 179500 (12.1%) | −324.0 | −324.0 | 0.26 |
| AR SRX1067071 | LHSAR Prostate | 475 / 17950 (2.6%) | 18636 / 179500 (10.4%) | −324.0 | −324.0 | 0.25 |
| FOS SRX150477 | MCF 10A Breast | 519 / 17950 (2.9%) | 21207 / 179500 (11.8%) | −324.0 | −324.0 | 0.24 |
| YAP1 SRX757325 | H2052 Lung | 487 / 17950 (2.7%) | 22082 / 179500 (12.3%) | −324.0 | −324.0 | 0.22 |
| YAP1 SRX757326 | H2052 Lung | 396 / 17950 (2.2%) | 19730 / 179500 (11.0%) | −324.0 | −324.0 | 0.20 |
| HIF1A SRX20663235 | HK-2 Kidney | 506 / 17950 (2.8%) | 286 / 179500 (0.2%) | −317.8 | −314.8 | 17.69 |
| FOS SRX4192880 | MCF 10A Breast | 404 / 17950 (2.3%) | 17118 / 179500 (9.5%) | −316.0 | −312.9 | 0.24 |
| LEO1 SRX1873456 | SEM Blood | 1818 / 17950 (10.1%) | 6239 / 179500 (3.5%) | −301.5 | −298.5 | 2.91 |
| SS18 SRX3468047 | Fibroblasts Others | 700 / 17950 (3.9%) | 21645 / 179500 (12.1%) | −300.2 | −297.2 | 0.32 |
| FOS SRX150517 | MCF 10A Breast | 432 / 17950 (2.4%) | 17125 / 179500 (9.5%) | −299.1 | −296.1 | 0.25 |
| Epitope tags SRX10549776 | K-562 Blood | 1677 / 17950 (9.3%) | 5469 / 179500 (3.0%) | −298.2 | −295.2 | 3.07 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 443 / 17950 (2.5%) | 204 / 179500 (0.1%) | −298.1 | −295.1 | 21.72 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 655 / 17950 (3.6%) | 20827 / 179500 (11.6%) | −297.1 | −294.1 | 0.31 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 984 / 17950 (5.5%) | 25893 / 179500 (14.4%) | −297.0 | −294.0 | 0.38 |
| AR SRX1067070 | LHSAR Prostate | 684 / 17950 (3.8%) | 21178 / 179500 (11.8%) | −293.6 | −290.6 | 0.32 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 989 / 17950 (5.5%) | 25707 / 179500 (14.3%) | −289.5 | −286.5 | 0.38 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 590 / 17950 (3.3%) | 19306 / 179500 (10.8%) | −282.5 | −279.6 | 0.31 |
| JUNB SRX8488073 | SUM 229PE Breast | 509 / 17950 (2.8%) | 17943 / 179500 (10.0%) | −282.1 | −279.1 | 0.28 |
| ESR1 SRX4367193 | MCF-7 Breast | 986 / 17950 (5.5%) | 25245 / 179500 (14.1%) | −277.3 | −274.4 | 0.39 |
| JUNB SRX8488088 | SUM 229PE Breast | 535 / 17950 (3.0%) | 18213 / 179500 (10.1%) | −276.7 | −273.8 | 0.29 |
| FOS SRX4192879 | MCF 10A Breast | 276 / 17950 (1.5%) | 13497 / 179500 (7.5%) | −273.4 | −270.5 | 0.20 |
| TP53 SRX19538279 | Osteoblasts Bone | 455 / 17950 (2.5%) | 292 / 179500 (0.2%) | −272.3 | −269.5 | 15.58 |
| GATA3 SRX190194 | SK-N-SH Neural | 702 / 17950 (3.9%) | 20713 / 179500 (11.5%) | −270.5 | −267.7 | 0.34 |
| JUN SRX17561461 | LPS141 Adipocyte | 390 / 17950 (2.2%) | 15413 / 179500 (8.6%) | −266.7 | −263.8 | 0.25 |
| NR3C1 SRX2609664 | HASM2 Lung | 363 / 17950 (2.0%) | 14930 / 179500 (8.3%) | −266.7 | −263.8 | 0.24 |
| AGO2 SRX4708039 | Hep G2 Liver | 1977 / 17950 (11.0%) | 7779 / 179500 (4.3%) | −263.9 | −261.0 | 2.54 |
| SMARCA2 SRX8119677 | MeT-5A Others | 458 / 17950 (2.6%) | 16483 / 179500 (9.2%) | −262.8 | −260.0 | 0.28 |
| FOS SRX150476 | MCF 10A Breast | 500 / 17950 (2.8%) | 17173 / 179500 (9.6%) | −262.2 | −259.4 | 0.29 |
| ESR1 SRX176860 | MCF-7 Breast | 473 / 17950 (2.6%) | 16701 / 179500 (9.3%) | −261.6 | −258.8 | 0.28 |
| SMARCA4 SRX5212366 | Mel270 Others | 359 / 17950 (2.0%) | 14647 / 179500 (8.2%) | −259.6 | −256.8 | 0.25 |
| MAU2 SRX15710550 | Fibroblasts Others | 462 / 17950 (2.6%) | 16436 / 179500 (9.2%) | −259.2 | −256.4 | 0.28 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1007 / 17950 (5.6%) | 24900 / 179500 (13.9%) | −258.9 | −256.1 | 0.40 |
| YAP1 SRX5718140 | 293 Kidney | 487 / 17950 (2.7%) | 16849 / 179500 (9.4%) | −258.8 | −256.0 | 0.29 |
| TCF12 SRX190356 | SK-N-SH Neural | 847 / 17950 (4.7%) | 22537 / 179500 (12.6%) | −258.8 | −256.0 | 0.38 |
| KAT7 SRX101303 | RKO Digestive tract | 1560 / 17950 (8.7%) | 5344 / 179500 (3.0%) | −257.5 | −254.8 | 2.92 |
| ESR1 SRX7624157 | MCF-7 Breast | 808 / 17950 (4.5%) | 21904 / 179500 (12.2%) | −257.5 | −254.7 | 0.37 |
| JUN SRX6582171 | GM07492 Others | 571 / 17950 (3.2%) | 18148 / 179500 (10.1%) | −255.9 | −253.2 | 0.31 |
| ESR1 SRX20282961 | MCF-7 Breast | 356 / 17950 (2.0%) | 14441 / 179500 (8.0%) | −254.5 | −251.8 | 0.25 |
| ESR1 SRX371478 | MCF-7 Breast | 365 / 17950 (2.0%) | 14601 / 179500 (8.1%) | −254.5 | −251.7 | 0.25 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 688 / 17950 (3.8%) | 19934 / 179500 (11.1%) | −253.6 | −250.9 | 0.35 |
| SMARCA4 SRX5212362 | Mel270 Others | 504 / 17950 (2.8%) | 16911 / 179500 (9.4%) | −251.8 | −249.1 | 0.30 |
| BRD1 SRX286203 | RKO Digestive tract | 1362 / 17950 (7.6%) | 4310 / 179500 (2.4%) | −250.6 | −247.9 | 3.16 |
| ESR1 SRX176861 | MCF-7 Breast | 495 / 17950 (2.8%) | 16718 / 179500 (9.3%) | −250.4 | −247.7 | 0.30 |
| NR3C1 SRX2609662 | HASM2 Lung | 315 / 17950 (1.8%) | 13553 / 179500 (7.6%) | −249.9 | −247.2 | 0.23 |
| SMARCA4 SRX5212357 | Mel270 Others | 408 / 17950 (2.3%) | 15210 / 179500 (8.5%) | −249.6 | −246.9 | 0.27 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1171 / 17950 (6.5%) | 26891 / 179500 (15.0%) | −249.5 | −246.8 | 0.44 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 265 / 17950 (1.5%) | 12571 / 179500 (7.0%) | −248.4 | −245.7 | 0.21 |
| NR3C1 SRX2609665 | HASM2 Lung | 287 / 17950 (1.6%) | 12970 / 179500 (7.2%) | −247.9 | −245.2 | 0.22 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 593 / 17950 (3.3%) | 18229 / 179500 (10.2%) | −247.6 | −244.9 | 0.33 |
| SMARCA4 SRX5212371 | Mel270 Others | 401 / 17950 (2.2%) | 15007 / 179500 (8.4%) | −247.0 | −244.3 | 0.27 |
| TP53 SRX19538274 | U2OS Bone | 380 / 17950 (2.1%) | 195 / 179500 (0.1%) | −246.7 | −244.1 | 19.49 |
| NR3C1 SRX2609659 | HASM2 Lung | 315 / 17950 (1.8%) | 13428 / 179500 (7.5%) | −245.7 | −243.1 | 0.23 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 653 / 17950 (3.6%) | 995 / 179500 (0.6%) | −245.7 | −243.0 | 6.56 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1291 / 17950 (7.2%) | 3995 / 179500 (2.2%) | −244.5 | −241.8 | 3.23 |
| ESR1 SRX7624156 | MCF-7 Breast | 492 / 17950 (2.7%) | 16471 / 179500 (9.2%) | −244.2 | −241.6 | 0.30 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 527 / 17950 (2.9%) | 17049 / 179500 (9.5%) | −244.2 | −241.6 | 0.31 |
| ESR1 SRX20282960 | MCF-7 Breast | 329 / 17950 (1.8%) | 13583 / 179500 (7.6%) | −242.3 | −239.7 | 0.24 |
| JUNB SRX10119386 | MCF 10A Breast | 228 / 17950 (1.3%) | 11667 / 179500 (6.5%) | −242.2 | −239.5 | 0.20 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 935 / 17950 (5.2%) | 23248 / 179500 (13.0%) | −242.1 | −239.4 | 0.40 |
| ESR1 SRX371469 | MCF-7 Breast | 301 / 17950 (1.7%) | 13055 / 179500 (7.3%) | −241.7 | −239.1 | 0.23 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 752 / 17950 (4.2%) | 20482 / 179500 (11.4%) | −240.8 | −238.2 | 0.37 |
| NR3C1 SRX2609661 | HASM2 Lung | 304 / 17950 (1.7%) | 13036 / 179500 (7.3%) | −239.2 | −236.6 | 0.23 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 783 / 17950 (4.4%) | 20879 / 179500 (11.6%) | −238.7 | −236.1 | 0.38 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 348 / 17950 (1.9%) | 13812 / 179500 (7.7%) | −238.5 | −235.9 | 0.25 |
| EP300 SRX2671813 | Fibroblasts Others | 208 / 17950 (1.2%) | 11153 / 179500 (6.2%) | −238.1 | −235.5 | 0.19 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 950 / 17950 (5.3%) | 23314 / 179500 (13.0%) | −237.8 | −235.2 | 0.41 |
| ESR1 SRX371479 | MCF-7 Breast | 255 / 17950 (1.4%) | 12066 / 179500 (6.7%) | −237.6 | −235.0 | 0.21 |
| JUNB SRX8488074 | SUM 229PE Breast | 390 / 17950 (2.2%) | 14484 / 179500 (8.1%) | −236.1 | −233.6 | 0.27 |
| ESR1 SRX1531791 | MCF-7 Breast | 273 / 17950 (1.5%) | 12358 / 179500 (6.9%) | −235.8 | −233.3 | 0.22 |
| AR SRX10820653 | LNCAP Prostate | 362 / 17950 (2.0%) | 186 / 179500 (0.1%) | −234.9 | −232.4 | 19.46 |
| TP53 SRX19538268 | U2OS Bone | 372 / 17950 (2.1%) | 208 / 179500 (0.1%) | −234.4 | −231.9 | 17.88 |
| NR3C1 SRX2609666 | HASM2 Lung | 253 / 17950 (1.4%) | 11886 / 179500 (6.6%) | −232.8 | −230.2 | 0.21 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 363 / 17950 (2.0%) | 13853 / 179500 (7.7%) | −231.0 | −228.5 | 0.26 |
| ESR1 SRX20282939 | MCF-7 Breast | 346 / 17950 (1.9%) | 13532 / 179500 (7.5%) | −230.4 | −227.8 | 0.26 |
| ESR1 SRX20282972 | MCF-7 Breast | 332 / 17950 (1.8%) | 13273 / 179500 (7.4%) | −230.1 | −227.6 | 0.25 |
| ESR1 SRX20282954 | MCF-7 Breast | 325 / 17950 (1.8%) | 13143 / 179500 (7.3%) | −230.1 | −227.5 | 0.25 |
| EP300 SRX2194266 | SUM 159PT Breast | 544 / 17950 (3.0%) | 16860 / 179500 (9.4%) | −229.9 | −227.4 | 0.32 |
| JUN SRX6582172 | Fibroblasts Others | 398 / 17950 (2.2%) | 14421 / 179500 (8.0%) | −229.7 | −227.1 | 0.28 |
| JUN SRX4192884 | MCF 10A Breast | 223 / 17950 (1.2%) | 11214 / 179500 (6.2%) | −229.6 | −227.1 | 0.20 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 543 / 17950 (3.0%) | 16821 / 179500 (9.4%) | −229.2 | −226.7 | 0.32 |
| JUNB SRX8488089 | SUM 229PE Breast | 279 / 17950 (1.6%) | 12273 / 179500 (6.8%) | −229.1 | −226.6 | 0.23 |
| TP53 SRX19538276 | U2OS Bone | 369 / 17950 (2.1%) | 215 / 179500 (0.1%) | −229.1 | −226.6 | 17.16 |
| BRPF3 SRX796084 | RKO Digestive tract | 1670 / 17950 (9.3%) | 6444 / 179500 (3.6%) | −228.4 | −225.9 | 2.59 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1319 / 17950 (7.3%) | 28120 / 179500 (15.7%) | −228.3 | −225.8 | 0.47 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 539 / 17950 (3.0%) | 16704 / 179500 (9.3%) | −227.7 | −225.2 | 0.32 |
| FOSL2 SRX190296 | SK-N-SH Neural | 408 / 17950 (2.3%) | 14496 / 179500 (8.1%) | −226.6 | −224.1 | 0.28 |
| BRPF3 SRX796085 | RKO Digestive tract | 1202 / 17950 (6.7%) | 3759 / 179500 (2.1%) | −223.9 | −221.4 | 3.20 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 476 / 17950 (2.7%) | 15528 / 179500 (8.7%) | −223.0 | −220.6 | 0.31 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 1036 / 17950 (5.8%) | 2889 / 179500 (1.6%) | −222.7 | −220.2 | 3.59 |
| TP53 SRX19538267 | U2OS Bone | 343 / 17950 (1.9%) | 177 / 179500 (0.1%) | −222.3 | −219.8 | 19.38 |
| YAP1 SRX10119364 | MCF 10A Breast | 233 / 17950 (1.3%) | 11163 / 179500 (6.2%) | −221.1 | −218.7 | 0.21 |
| BMI1 SRX644729 | 293 Kidney | 304 / 17950 (1.7%) | 107 / 179500 (0.1%) | −220.9 | −218.5 | 28.41 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 644 / 17950 (3.6%) | 18135 / 179500 (10.1%) | −220.8 | −218.4 | 0.36 |
| WWTR1 SRX10119367 | MCF 10A Breast | 354 / 17950 (2.0%) | 13373 / 179500 (7.5%) | −220.6 | −218.2 | 0.26 |
| JUND SRX190357 | SK-N-SH Neural | 392 / 17950 (2.2%) | 14025 / 179500 (7.8%) | −220.4 | −217.9 | 0.28 |
| JUNB SRX4192882 | MCF 10A Breast | 218 / 17950 (1.2%) | 10844 / 179500 (6.0%) | −220.2 | −217.7 | 0.20 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 420 / 17950 (2.3%) | 14488 / 179500 (8.1%) | −219.9 | −217.4 | 0.29 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 243 / 17950 (1.4%) | 11317 / 179500 (6.3%) | −219.7 | −217.3 | 0.21 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 270 / 17950 (1.5%) | 11817 / 179500 (6.6%) | −219.4 | −217.0 | 0.23 |
| ESR1 SRX10365535 | MCF-7 Breast | 224 / 17950 (1.2%) | 10915 / 179500 (6.1%) | −218.6 | −216.1 | 0.21 |
| FOXA1 SRX4815197 | MCF-7 Breast | 846 / 17950 (4.7%) | 21083 / 179500 (11.7%) | −218.1 | −215.7 | 0.40 |
| ESR1 SRX4367192 | MCF-7 Breast | 683 / 17950 (3.8%) | 18624 / 179500 (10.4%) | −217.6 | −215.2 | 0.37 |
| FOXA1 SRX176862 | MCF-7 Breast | 443 / 17950 (2.5%) | 14794 / 179500 (8.2%) | −217.3 | −214.9 | 0.30 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 448 / 17950 (2.5%) | 14875 / 179500 (8.3%) | −217.2 | −214.8 | 0.30 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 302 / 17950 (1.7%) | 12338 / 179500 (6.9%) | −217.2 | −214.7 | 0.24 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 410 / 17950 (2.3%) | 14227 / 179500 (7.9%) | −216.9 | −214.5 | 0.29 |
| VGLL1 SRX24602130 | BT-20 Breast | 314 / 17950 (1.7%) | 12526 / 179500 (7.0%) | −216.3 | −213.8 | 0.25 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 650 / 17950 (3.6%) | 18056 / 179500 (10.1%) | −215.8 | −213.3 | 0.36 |
| EP300 SRX150579 | HeLa Uterus | 175 / 17950 (1.0%) | 9845 / 179500 (5.5%) | −215.5 | −213.1 | 0.18 |
| ING5 SRX286202 | RKO Digestive tract | 1464 / 17950 (8.2%) | 5407 / 179500 (3.0%) | −214.2 | −211.8 | 2.71 |
| TP53 SRX19538280 | Osteoblasts Bone | 359 / 17950 (2.0%) | 233 / 179500 (0.1%) | −213.9 | −211.5 | 15.41 |
| ESR1 SRX371467 | MCF-7 Breast | 341 / 17950 (1.9%) | 12919 / 179500 (7.2%) | −213.3 | −210.9 | 0.26 |
| JUN SRX883584 | MDA-MB-231 Breast | 520 / 17950 (2.9%) | 15890 / 179500 (8.9%) | −212.3 | −209.9 | 0.33 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 169 / 17950 (0.9%) | 9602 / 179500 (5.3%) | −211.1 | −208.7 | 0.18 |
| ESR1 SRX371476 | MCF-7 Breast | 228 / 17950 (1.3%) | 10753 / 179500 (6.0%) | −210.3 | −207.9 | 0.21 |
| ESR1 SRX20282955 | MCF-7 Breast | 335 / 17950 (1.9%) | 12714 / 179500 (7.1%) | −210.1 | −207.8 | 0.26 |
| EP300 SRX2194265 | SUM 159PT Breast | 524 / 17950 (2.9%) | 15877 / 179500 (8.8%) | −210.0 | −207.6 | 0.33 |
| STAT3 SRX150630 | MCF 10A Breast | 284 / 17950 (1.6%) | 11763 / 179500 (6.6%) | −209.0 | −206.7 | 0.24 |
| ESR1 SRX194569 | MCF-7 Breast | 346 / 17950 (1.9%) | 12870 / 179500 (7.2%) | −208.9 | −206.5 | 0.27 |
| JUN SRX7277180 | GM07492 Others | 244 / 17950 (1.4%) | 11013 / 179500 (6.1%) | −208.7 | −206.3 | 0.22 |
| ESR1 SRX20282973 | MCF-7 Breast | 393 / 17950 (2.2%) | 13673 / 179500 (7.6%) | −208.7 | −206.3 | 0.29 |
| FOXA1 SRX371481 | MCF-7 Breast | 358 / 17950 (2.0%) | 13069 / 179500 (7.3%) | −208.6 | −206.3 | 0.27 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 610 / 17950 (3.4%) | 1054 / 179500 (0.6%) | −208.5 | −206.1 | 5.79 |
| KMT2A SRX5732680 | MOLM-13 Blood | 1523 / 17950 (8.5%) | 5862 / 179500 (3.3%) | −208.3 | −205.9 | 2.60 |
| JUNB SRX10119383 | MCF 10A Breast | 193 / 17950 (1.1%) | 10000 / 179500 (5.6%) | −208.1 | −205.7 | 0.19 |
| STAT3 SRX150479 | MCF 10A Breast | 288 / 17950 (1.6%) | 11807 / 179500 (6.6%) | −208.0 | −205.7 | 0.24 |
| CEBPB SRX150632 | HeLa Uterus | 796 / 17950 (4.4%) | 19978 / 179500 (11.1%) | −208.0 | −205.6 | 0.40 |
| PBX3 SRX190343 | SK-N-SH Neural | 725 / 17950 (4.0%) | 18914 / 179500 (10.5%) | −207.8 | −205.5 | 0.38 |
| NR3C1 SRX10976921 | A549 Lung | 199 / 17950 (1.1%) | 10088 / 179500 (5.6%) | −206.9 | −204.6 | 0.20 |
| JUNB SRX10119384 | MCF 10A Breast | 165 / 17950 (0.9%) | 9366 / 179500 (5.2%) | −205.7 | −203.4 | 0.18 |
| BRPF3 SRX796086 | RKO Digestive tract | 1567 / 17950 (8.7%) | 6181 / 179500 (3.4%) | −205.5 | −203.2 | 2.54 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 598 / 17950 (3.3%) | 16885 / 179500 (9.4%) | −205.2 | −202.9 | 0.35 |
| TP53 SRX19538281 | Osteoblasts Bone | 383 / 17950 (2.1%) | 318 / 179500 (0.2%) | −205.2 | −202.8 | 12.04 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 447 / 17950 (2.5%) | 14457 / 179500 (8.1%) | −205.0 | −202.6 | 0.31 |
| SUPT5H SRX2314263 | MOLT-4 Blood | 1890 / 17950 (10.5%) | 8299 / 179500 (4.6%) | −204.3 | −202.0 | 2.28 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 256 / 17950 (1.4%) | 11106 / 179500 (6.2%) | −204.3 | −202.0 | 0.23 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1209 / 17950 (6.7%) | 25667 / 179500 (14.3%) | −204.2 | −201.9 | 0.47 |
| AR SRX10820651 | LNCAP Prostate | 375 / 17950 (2.1%) | 301 / 179500 (0.2%) | −204.0 | −201.7 | 12.46 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 603 / 17950 (3.4%) | 16907 / 179500 (9.4%) | −203.6 | −201.3 | 0.36 |
| RAG2 SRX1046558 | Thymus Blood | 2223 / 17950 (12.4%) | 10622 / 179500 (5.9%) | −202.4 | −200.1 | 2.09 |
| ESR1 SRX10365536 | MCF-7 Breast | 149 / 17950 (0.8%) | 8920 / 179500 (5.0%) | −201.8 | −199.5 | 0.17 |
| ESR1 SRX371468 | MCF-7 Breast | 199 / 17950 (1.1%) | 9929 / 179500 (5.5%) | −201.4 | −199.1 | 0.20 |
| AR SRX1067067 | LHSAR Prostate | 601 / 17950 (3.3%) | 16794 / 179500 (9.4%) | −201.2 | −198.9 | 0.36 |
| FOXA1 SRX176863 | MCF-7 Breast | 428 / 17950 (2.4%) | 14022 / 179500 (7.8%) | −201.2 | −198.9 | 0.31 |
| PRRX1 SRX15235713 | Hs 578T Breast | 405 / 17950 (2.3%) | 13625 / 179500 (7.6%) | −200.9 | −198.6 | 0.30 |
| ESR1 SRX194572 | MCF-7 Breast | 198 / 17950 (1.1%) | 9891 / 179500 (5.5%) | −200.7 | −198.4 | 0.20 |
| TP53 SRX19538273 | U2OS Bone | 318 / 17950 (1.8%) | 178 / 179500 (0.1%) | −200.3 | −198.0 | 17.87 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 505 / 17950 (2.8%) | 15246 / 179500 (8.5%) | −200.3 | −198.0 | 0.33 |
| TP53 SRX19538275 | U2OS Bone | 328 / 17950 (1.8%) | 200 / 179500 (0.1%) | −200.2 | −197.9 | 16.40 |
| MEAF6 DRX234811 | 293 Kidney | 1818 / 17950 (10.1%) | 7908 / 179500 (4.4%) | −199.9 | −197.6 | 2.30 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 821 / 17950 (4.6%) | 20042 / 179500 (11.2%) | −199.8 | −197.6 | 0.41 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 868 / 17950 (4.8%) | 2280 / 179500 (1.3%) | −199.5 | −197.2 | 3.81 |
| ESR1 SRX2881002 | MCF-7 Breast | 311 / 17950 (1.7%) | 11948 / 179500 (6.7%) | −199.1 | −196.8 | 0.26 |
| TLE3 SRX4815191 | MCF-7 Breast | 338 / 17950 (1.9%) | 12416 / 179500 (6.9%) | −198.8 | −196.6 | 0.27 |
| MEAF6 DRX300417 | 293 Kidney | 1679 / 17950 (9.4%) | 7019 / 179500 (3.9%) | −198.6 | −196.3 | 2.39 |
| ESR1 SRX2881000 | MCF-7 Breast | 283 / 17950 (1.6%) | 11425 / 179500 (6.4%) | −198.5 | −196.2 | 0.25 |
| JUND SRX150408 | HeLa Uterus | 280 / 17950 (1.6%) | 11349 / 179500 (6.3%) | −197.8 | −195.5 | 0.25 |
| FOXA1 SRX1161177 | MCF-7 Breast | 360 / 17950 (2.0%) | 12753 / 179500 (7.1%) | −197.5 | −195.2 | 0.28 |
| ESR1 SRX20282940 | MCF-7 Breast | 367 / 17950 (2.0%) | 12870 / 179500 (7.2%) | −197.4 | −195.1 | 0.29 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 913 / 17950 (5.1%) | 21265 / 179500 (11.8%) | −197.1 | −194.9 | 0.43 |
| RAC1 SRX10365543 | MCF-7 Breast | 157 / 17950 (0.9%) | 8950 / 179500 (5.0%) | −196.9 | −194.7 | 0.18 |
| ESR1 SRX330067 | MCF-7 Breast | 296 / 17950 (1.6%) | 11605 / 179500 (6.5%) | −196.6 | −194.4 | 0.26 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 521 / 17950 (2.9%) | 15377 / 179500 (8.6%) | −196.5 | −194.3 | 0.34 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 832 / 17950 (4.6%) | 2136 / 179500 (1.2%) | −196.1 | −193.9 | 3.90 |
| NR3C1 SRX10977357 | A549 Lung | 178 / 17950 (1.0%) | 9359 / 179500 (5.2%) | −196.1 | −193.8 | 0.19 |
| Epitope tags DRX443510 | 293 Kidney | 1596 / 17950 (8.9%) | 6531 / 179500 (3.6%) | −196.0 | −193.8 | 2.44 |
| GATA3 SRX190239 | MCF-7 Breast | 537 / 17950 (3.0%) | 15611 / 179500 (8.7%) | −196.0 | −193.7 | 0.34 |
| WWTR1 SRX10119378 | MCF 10A Breast | 364 / 17950 (2.0%) | 12731 / 179500 (7.1%) | −194.6 | −192.3 | 0.29 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 468 / 17950 (2.6%) | 14459 / 179500 (8.1%) | −194.6 | −192.3 | 0.32 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 910 / 17950 (5.1%) | 2544 / 179500 (1.4%) | −194.5 | −192.3 | 3.58 |
| FOXA1 SRX371482 | MCF-7 Breast | 531 / 17950 (3.0%) | 15460 / 179500 (8.6%) | −194.3 | −192.1 | 0.34 |
| NR3C1 SRX10977372 | A549 Lung | 164 / 17950 (0.9%) | 9022 / 179500 (5.0%) | −194.2 | −192.0 | 0.18 |
| JUN SRX2355072 | HAEC Cardiovascular | 459 / 17950 (2.6%) | 14295 / 179500 (8.0%) | −194.1 | −191.9 | 0.32 |
| GATA3 SRX5057632 | MCF-7 Breast | 212 / 17950 (1.2%) | 9967 / 179500 (5.6%) | −194.0 | −191.7 | 0.21 |
| FOXA1 SRX371483 | MCF-7 Breast | 412 / 17950 (2.3%) | 13516 / 179500 (7.5%) | −193.9 | −191.7 | 0.30 |
| JUN SRX6582163 | BJ-5ta Epidermis | 432 / 17950 (2.4%) | 13815 / 179500 (7.7%) | −193.0 | −190.7 | 0.31 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 544 / 17950 (3.0%) | 15611 / 179500 (8.7%) | −192.8 | −190.6 | 0.35 |
| EP300 ERX626811 | U-937 Blood | 1352 / 17950 (7.5%) | 5071 / 179500 (2.8%) | −192.2 | −190.0 | 2.67 |
| GATA3 SRX176864 | MCF-7 Breast | 250 / 17950 (1.4%) | 10618 / 179500 (5.9%) | −191.8 | −189.6 | 0.24 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 274 / 17950 (1.5%) | 11037 / 179500 (6.1%) | −191.1 | −188.8 | 0.25 |
| ESR1 SRX371471 | ZR-75-1 Breast | 399 / 17950 (2.2%) | 13198 / 179500 (7.4%) | −190.8 | −188.6 | 0.30 |
| ESR1 SRX20282971 | MCF-7 Breast | 337 / 17950 (1.9%) | 12128 / 179500 (6.8%) | −190.3 | −188.1 | 0.28 |
| ESR1 SRX1469949 | MCF-7 Breast | 172 / 17950 (1.0%) | 9065 / 179500 (5.1%) | −190.0 | −187.8 | 0.19 |
| EP300 ERX626821 | U-937 Blood | 1342 / 17950 (7.5%) | 5050 / 179500 (2.8%) | −189.7 | −187.5 | 2.66 |
| SUPT5H SRX2314264 | MOLT-4 Blood | 1777 / 17950 (9.9%) | 7838 / 179500 (4.4%) | −189.6 | −187.4 | 2.27 |
| Epitope tags SRX10549778 | K-562 Blood | 1220 / 17950 (6.8%) | 4328 / 179500 (2.4%) | −189.0 | −186.8 | 2.82 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 244 / 17950 (1.4%) | 10411 / 179500 (5.8%) | −188.6 | −186.4 | 0.23 |
| ESR1 SRX11120903 | MCF-7 Breast | 291 / 17950 (1.6%) | 11254 / 179500 (6.3%) | −188.3 | −186.1 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 170 / 17950 (0.9%) | 8968 / 179500 (5.0%) | −188.0 | −185.8 | 0.19 |
| NR3C1 SRX10977373 | A549 Lung | 161 / 17950 (0.9%) | 8781 / 179500 (4.9%) | −187.9 | −185.7 | 0.18 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 382 / 17950 (2.1%) | 12818 / 179500 (7.1%) | −187.8 | −185.6 | 0.30 |
| AR SRX1067066 | LHSAR Prostate | 786 / 17950 (4.4%) | 19075 / 179500 (10.6%) | −187.6 | −185.4 | 0.41 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 270 / 17950 (1.5%) | 10856 / 179500 (6.0%) | −187.6 | −185.4 | 0.25 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 317 / 17950 (1.8%) | 11676 / 179500 (6.5%) | −186.9 | −184.8 | 0.27 |
| ESR1 SRX3110725 | MCF-7 Breast | 308 / 17950 (1.7%) | 11516 / 179500 (6.4%) | −186.9 | −184.7 | 0.27 |
| ESR1 SRX20282953 | MCF-7 Breast | 274 / 17950 (1.5%) | 10909 / 179500 (6.1%) | −186.8 | −184.7 | 0.25 |
| EP300 SRX100540 | SK-N-SH Neural | 527 / 17950 (2.9%) | 15127 / 179500 (8.4%) | −186.5 | −184.3 | 0.35 |
| ESR1 SRX8537722 | MCF-7 Breast | 320 / 17950 (1.8%) | 11684 / 179500 (6.5%) | −185.6 | −183.5 | 0.27 |
| ESR1 SRX1012629 | MCF-7 Breast | 202 / 17950 (1.1%) | 9522 / 179500 (5.3%) | −185.5 | −183.3 | 0.21 |
| JUN SRX6582165 | BJ-5ta Epidermis | 705 / 17950 (3.9%) | 17805 / 179500 (9.9%) | −185.4 | −183.3 | 0.40 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 467 / 17950 (2.6%) | 14132 / 179500 (7.9%) | −185.3 | −183.2 | 0.33 |
| FOS SRX150664 | HUVEC Cardiovascular | 476 / 17950 (2.7%) | 14266 / 179500 (7.9%) | −185.0 | −182.8 | 0.33 |
| ESR1 SRX10365558 | MCF-7 Breast | 219 / 17950 (1.2%) | 9823 / 179500 (5.5%) | −184.7 | −182.5 | 0.22 |
| ESR1 SRX330069 | MCF-7 Breast | 201 / 17950 (1.1%) | 9473 / 179500 (5.3%) | −184.5 | −182.3 | 0.21 |
| WWTR1 SRX10119368 | MCF 10A Breast | 231 / 17950 (1.3%) | 10046 / 179500 (5.6%) | −184.4 | −182.3 | 0.23 |
| ARID1A SRX5089376 | MCF-7 Breast | 308 / 17950 (1.7%) | 11427 / 179500 (6.4%) | −184.1 | −182.0 | 0.27 |
| TP53 SRX19538269 | U2OS Bone | 408 / 17950 (2.3%) | 470 / 179500 (0.3%) | −183.9 | −181.8 | 8.68 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 319 / 17950 (1.8%) | 11615 / 179500 (6.5%) | −183.9 | −181.8 | 0.27 |
| YAP1 SRX1038945 | IMR-90 Lung | 251 / 17950 (1.4%) | 10397 / 179500 (5.8%) | −183.9 | −181.7 | 0.24 |
| FOXA1 SRX1161176 | MCF-7 Breast | 358 / 17950 (2.0%) | 12278 / 179500 (6.8%) | −183.8 | −181.6 | 0.29 |
| EP300 SRX10976625 | A549 Lung | 178 / 17950 (1.0%) | 9001 / 179500 (5.0%) | −183.6 | −181.5 | 0.20 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 232 / 17950 (1.3%) | 10010 / 179500 (5.6%) | −182.7 | −180.5 | 0.23 |
| ARID1A SRX5679788 | 12Z Others | 123 / 17950 (0.7%) | 7822 / 179500 (4.4%) | −182.2 | −180.0 | 0.16 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 655 / 17950 (3.6%) | 1431 / 179500 (0.8%) | −182.2 | −180.0 | 4.58 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 334 / 17950 (1.9%) | 11815 / 179500 (6.6%) | −182.1 | −180.0 | 0.28 |
| NR3C1 SRX17639412 | A549 Lung | 399 / 17950 (2.2%) | 12913 / 179500 (7.2%) | −182.1 | −180.0 | 0.31 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 580 / 17950 (3.2%) | 15798 / 179500 (8.8%) | −182.1 | −180.0 | 0.37 |
| FOS SRX070879 | HUVEC Cardiovascular | 379 / 17950 (2.1%) | 12576 / 179500 (7.0%) | −182.0 | −179.9 | 0.30 |
| AGO2 SRX6783958 | Hep G2 Liver | 1243 / 17950 (6.9%) | 4581 / 179500 (2.6%) | −181.3 | −179.1 | 2.71 |
| DAXX SRX1021630 | PC-3 Prostate | 361 / 17950 (2.0%) | 12232 / 179500 (6.8%) | −180.6 | −178.5 | 0.30 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 663 / 17950 (3.7%) | 16946 / 179500 (9.4%) | −179.1 | −177.0 | 0.39 |
| ESR1 SRX20282938 | MCF-7 Breast | 280 / 17950 (1.6%) | 10776 / 179500 (6.0%) | −179.0 | −176.9 | 0.26 |
| ESR1 SRX371470 | ZR-75-1 Breast | 354 / 17950 (2.0%) | 12040 / 179500 (6.7%) | −178.4 | −176.3 | 0.29 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 498 / 17950 (2.8%) | 14387 / 179500 (8.0%) | −178.4 | −176.3 | 0.35 |
| KAT7 DRX234808 | 293 Kidney | 846 / 17950 (4.7%) | 2389 / 179500 (1.3%) | −178.4 | −176.3 | 3.54 |
| ESR1 SRX1531796 | MCF-7 Breast | 173 / 17950 (1.0%) | 8735 / 179500 (4.9%) | −178.0 | −175.8 | 0.20 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 351 / 17950 (2.0%) | 11968 / 179500 (6.7%) | −177.8 | −175.7 | 0.29 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 650 / 17950 (3.6%) | 1446 / 179500 (0.8%) | −177.6 | −175.5 | 4.50 |
| NFIC SRX190336 | SK-N-SH Neural | 521 / 17950 (2.9%) | 14693 / 179500 (8.2%) | −176.8 | −174.7 | 0.35 |
| STAT3 SRX150536 | MCF 10A Breast | 413 / 17950 (2.3%) | 12966 / 179500 (7.2%) | −176.8 | −174.7 | 0.32 |
| ESR1 SRX20282946 | MCF-7 Breast | 206 / 17950 (1.1%) | 9338 / 179500 (5.2%) | −176.6 | −174.5 | 0.22 |
| ARID1A SRX5679787 | 12Z Others | 117 / 17950 (0.7%) | 7535 / 179500 (4.2%) | −176.6 | −174.5 | 0.16 |
| MITF SRX7368255 | Hermes 3C Epidermis | 1110 / 17950 (6.2%) | 23189 / 179500 (12.9%) | −176.6 | −174.5 | 0.48 |
| ESR1 SRX371477 | MCF-7 Breast | 168 / 17950 (0.9%) | 8593 / 179500 (4.8%) | −176.5 | −174.4 | 0.20 |
| FOXA1 SRX3931044 | MCF-7 Breast | 839 / 17950 (4.7%) | 19394 / 179500 (10.8%) | −175.9 | −173.8 | 0.43 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 550 / 17950 (3.1%) | 1031 / 179500 (0.6%) | −175.6 | −173.5 | 5.33 |
| JUNB SRX10119385 | MCF 10A Breast | 140 / 17950 (0.8%) | 7977 / 179500 (4.4%) | −174.9 | −172.8 | 0.18 |
| CEBPB SRX2194250 | SUM 159PT Breast | 456 / 17950 (2.5%) | 13596 / 179500 (7.6%) | −174.7 | −172.6 | 0.34 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 503 / 17950 (2.8%) | 14333 / 179500 (8.0%) | −174.6 | −172.5 | 0.35 |
| TCF21 DRX190655 | HCF Cardiovascular | 641 / 17950 (3.6%) | 16451 / 179500 (9.2%) | −174.6 | −172.5 | 0.39 |
| ARID1A SRX5089379 | MCF-7 Breast | 372 / 17950 (2.1%) | 12205 / 179500 (6.8%) | −174.2 | −172.1 | 0.30 |
| EP300 SRX10976215 | A549 Lung | 329 / 17950 (1.8%) | 11466 / 179500 (6.4%) | −173.9 | −171.8 | 0.29 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 500 / 17950 (2.8%) | 14266 / 179500 (7.9%) | −173.9 | −171.8 | 0.35 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 378 / 17950 (2.1%) | 12291 / 179500 (6.8%) | −173.8 | −171.7 | 0.31 |
| JUND SRX699738 | HCASMC Cardiovascular | 532 / 17950 (3.0%) | 14759 / 179500 (8.2%) | −173.7 | −171.6 | 0.36 |
| ESR1 SRX330070 | MCF-7 Breast | 176 / 17950 (1.0%) | 8662 / 179500 (4.8%) | −173.4 | −171.3 | 0.20 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 393 / 17950 (2.2%) | 12522 / 179500 (7.0%) | −173.3 | −171.2 | 0.31 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 260 / 17950 (1.4%) | 10234 / 179500 (5.7%) | −173.2 | −171.1 | 0.25 |
| ESR1 SRX1469951 | MCF-7 Breast | 171 / 17950 (1.0%) | 8550 / 179500 (4.8%) | −172.9 | −170.8 | 0.20 |
| FOXA1 SRX1161173 | MCF-7 Breast | 311 / 17950 (1.7%) | 11126 / 179500 (6.2%) | −172.9 | −170.8 | 0.28 |
| TLE3 SRX4815194 | SUM 149PT Breast | 269 / 17950 (1.5%) | 10387 / 179500 (5.8%) | −172.8 | −170.8 | 0.26 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 361 / 17950 (2.0%) | 11974 / 179500 (6.7%) | −172.8 | −170.7 | 0.30 |
| FOXA1 SRX371480 | MCF-7 Breast | 253 / 17950 (1.4%) | 10085 / 179500 (5.6%) | −172.5 | −170.4 | 0.25 |
| AGO2 SRX6783957 | Hep G2 Liver | 1242 / 17950 (6.9%) | 4717 / 179500 (2.6%) | −172.4 | −170.4 | 2.63 |
| ESR1 SRX2943591 | MCF-7 Breast | 255 / 17950 (1.4%) | 10116 / 179500 (5.6%) | −172.4 | −170.3 | 0.25 |
| JUN SRX6582164 | BJ-5ta Epidermis | 479 / 17950 (2.7%) | 13868 / 179500 (7.7%) | −172.0 | −170.0 | 0.35 |
| ESR1 SRX2912055 | MCF-7 Breast | 122 / 17950 (0.7%) | 7512 / 179500 (4.2%) | −171.9 | −169.8 | 0.16 |
| KMT2B DRX059615 | HB1119 Blood | 958 / 17950 (5.3%) | 3069 / 179500 (1.7%) | −171.6 | −169.6 | 3.12 |
| SSRP1 SRX3436567 | HT-1080 Bone | 427 / 17950 (2.4%) | 591 / 179500 (0.3%) | −171.5 | −169.4 | 7.23 |
| ESR1 SRX2513517 | MCF-7 Breast | 239 / 17950 (1.3%) | 9801 / 179500 (5.5%) | −171.4 | −169.4 | 0.24 |
| NR3C1 SRX8520802 | HCC1187 Breast | 270 / 17950 (1.5%) | 10356 / 179500 (5.8%) | −171.3 | −169.3 | 0.26 |
| FOXA1 SRX1161175 | MCF-7 Breast | 293 / 17950 (1.6%) | 10746 / 179500 (6.0%) | −170.9 | −168.8 | 0.27 |
| NR3C1 SRX18884271 | A549 Lung | 178 / 17950 (1.0%) | 8623 / 179500 (4.8%) | −170.7 | −168.7 | 0.21 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 755 / 17950 (4.2%) | 17981 / 179500 (10.0%) | −170.6 | −168.5 | 0.42 |
| EP300 SRX176885 | MCF-7 Breast | 180 / 17950 (1.0%) | 8650 / 179500 (4.8%) | −170.2 | −168.1 | 0.21 |
| PGR SRX1012655 | MCF-7 Breast | 230 / 17950 (1.3%) | 9590 / 179500 (5.3%) | −170.0 | −167.9 | 0.24 |
| ESR1 SRX8537723 | MCF-7 Breast | 293 / 17950 (1.6%) | 10716 / 179500 (6.0%) | −169.9 | −167.8 | 0.27 |
| STAT3 SRX2020842 | HCC70 Breast | 694 / 17950 (3.9%) | 17062 / 179500 (9.5%) | −169.8 | −167.8 | 0.41 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 829 / 17950 (4.6%) | 2396 / 179500 (1.3%) | −169.8 | −167.7 | 3.46 |
| ESR1 SRX10365532 | MCF-7 Breast | 194 / 17950 (1.1%) | 8902 / 179500 (5.0%) | −169.6 | −167.6 | 0.22 |
| ESR1 SRX20282959 | MCF-7 Breast | 135 / 17950 (0.8%) | 7722 / 179500 (4.3%) | −169.6 | −167.5 | 0.17 |
| ESR1 SRX1995229 | MCF-7 Breast | 371 / 17950 (2.1%) | 12036 / 179500 (6.7%) | −169.6 | −167.5 | 0.31 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1368 / 17950 (7.6%) | 5560 / 179500 (3.1%) | −169.1 | −167.0 | 2.46 |
| JUNB SRX2443774 | A549 Lung | 138 / 17950 (0.8%) | 7766 / 179500 (4.3%) | −168.8 | −166.8 | 0.18 |
| SETD1A SRX23734379 | MOLM-13 Blood | 1302 / 17950 (7.3%) | 5150 / 179500 (2.9%) | −168.7 | −166.6 | 2.53 |
| NR3C1 SRX17639413 | A549 Lung | 246 / 17950 (1.4%) | 9834 / 179500 (5.5%) | −168.5 | −166.4 | 0.25 |
| AFF1 SRX10484575 | RS4-11 Blood | 1537 / 17950 (8.6%) | 6667 / 179500 (3.7%) | −168.4 | −166.4 | 2.31 |
| CEBPB SRX1027438 | Mesenchymal stem cells Others | 497 / 17950 (2.8%) | 14021 / 179500 (7.8%) | −168.4 | −166.3 | 0.35 |
| ESR1 SRX3123829 | MCF-7 Breast | 206 / 17950 (1.1%) | 9082 / 179500 (5.1%) | −168.1 | −166.1 | 0.23 |
| TEAD1 SRX716558 | SF268 Neural | 173 / 17950 (1.0%) | 8447 / 179500 (4.7%) | −168.0 | −166.0 | 0.20 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 422 / 17950 (2.4%) | 12815 / 179500 (7.1%) | −167.9 | −165.8 | 0.33 |
| TEAD1 SRX3401272 | MCF-7 Breast | 284 / 17950 (1.6%) | 10494 / 179500 (5.8%) | −167.8 | −165.8 | 0.27 |
| ESR1 SRX371475 | BT-474 Breast | 183 / 17950 (1.0%) | 8628 / 179500 (4.8%) | −167.6 | −165.6 | 0.21 |
| ESR1 SRX1012633 | MCF-7 Breast | 180 / 17950 (1.0%) | 8558 / 179500 (4.8%) | −167.1 | −165.1 | 0.21 |
| FOXA1 SRX1787653 | MCF-7 Breast | 315 / 17950 (1.8%) | 11008 / 179500 (6.1%) | −167.1 | −165.1 | 0.29 |
| ESR1 SRX3110723 | MCF-7 Breast | 193 / 17950 (1.1%) | 8792 / 179500 (4.9%) | −166.7 | −164.6 | 0.22 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 342 / 17950 (1.9%) | 11447 / 179500 (6.4%) | −166.5 | −164.5 | 0.30 |
| BRD4 SRX1880278 | Jurkat Blood | 1957 / 17950 (10.9%) | 9586 / 179500 (5.3%) | −166.4 | −164.4 | 2.04 |
| NR3C1 SRX2609667 | HASM2 Lung | 373 / 17950 (2.1%) | 11957 / 179500 (6.7%) | −166.3 | −164.3 | 0.31 |
| ESR1 SRX1012632 | MCF-7 Breast | 174 / 17950 (1.0%) | 8401 / 179500 (4.7%) | −165.7 | −163.7 | 0.21 |
| NR3C1 SRX10977364 | A549 Lung | 144 / 17950 (0.8%) | 7799 / 179500 (4.3%) | −165.7 | −163.6 | 0.18 |
| ESR1 SRX5323871 | MCF-7 Breast | 423 / 17950 (2.4%) | 12742 / 179500 (7.1%) | −165.2 | −163.2 | 0.33 |
| JADE3 DRX234809 | 293 Kidney | 1085 / 17950 (6.0%) | 3885 / 179500 (2.2%) | −165.2 | −163.2 | 2.79 |
| Epitope tags SRX5877912 | U2OS Bone | 2238 / 17950 (12.5%) | 37019 / 179500 (20.6%) | −165.0 | −163.0 | 0.60 |
| FOXA1 SRX190181 | A549 Lung | 264 / 17950 (1.5%) | 10048 / 179500 (5.6%) | −164.9 | −162.9 | 0.26 |
| ESR1 SRX2881001 | MCF-7 Breast | 194 / 17950 (1.1%) | 8761 / 179500 (4.9%) | −164.9 | −162.9 | 0.22 |
| NR3C1 SRX10976392 | A549 Lung | 153 / 17950 (0.9%) | 7959 / 179500 (4.4%) | −164.8 | −162.8 | 0.19 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 326 / 17950 (1.8%) | 11117 / 179500 (6.2%) | −164.7 | −162.7 | 0.29 |
| NR3C1 SRX10976922 | A549 Lung | 137 / 17950 (0.8%) | 7629 / 179500 (4.3%) | −164.7 | −162.7 | 0.18 |
| SMAD3 SRX366168 | NCI-H441 Lung | 328 / 17950 (1.8%) | 11142 / 179500 (6.2%) | −164.3 | −162.3 | 0.29 |
| NR2F2 SRX190293 | MCF-7 Breast | 414 / 17950 (2.3%) | 12554 / 179500 (7.0%) | −164.1 | −162.1 | 0.33 |
| FOSL2 SRX190204 | A549 Lung | 378 / 17950 (2.1%) | 11961 / 179500 (6.7%) | −164.0 | −161.9 | 0.32 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 567 / 17950 (3.2%) | 14942 / 179500 (8.3%) | −163.9 | −161.9 | 0.38 |
| ESR1 SRX5323873 | MCF-7 Breast | 486 / 17950 (2.7%) | 13693 / 179500 (7.6%) | −163.9 | −161.9 | 0.35 |
| STAT1 SRX23678708 | K-562 Blood | 1585 / 17950 (8.8%) | 7078 / 179500 (3.9%) | −163.8 | −161.8 | 2.24 |
| EP300 SRX2194268 | SUM 159PT Breast | 144 / 17950 (0.8%) | 7740 / 179500 (4.3%) | −163.6 | −161.6 | 0.19 |
| STAT5B SRX831881 | CD8+ T cells Blood | 259 / 17950 (1.4%) | 144 / 179500 (0.1%) | −163.6 | −161.6 | 17.99 |
| ESR1 SRX330068 | MCF-7 Breast | 165 / 17950 (0.9%) | 8162 / 179500 (4.5%) | −163.6 | −161.6 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 356 / 17950 (2.0%) | 11584 / 179500 (6.5%) | −163.6 | −161.6 | 0.31 |
| TP53 SRX19538270 | U2OS Bone | 376 / 17950 (2.1%) | 460 / 179500 (0.3%) | −163.5 | −161.5 | 8.17 |
| ESR1 SRX5323872 | MCF-7 Breast | 386 / 17950 (2.2%) | 12076 / 179500 (6.7%) | −163.4 | −161.4 | 0.32 |
| ESR1 SRX5323878 | MCF-7 Breast | 387 / 17950 (2.2%) | 12092 / 179500 (6.7%) | −163.4 | −161.4 | 0.32 |
| MEN1 SRX11712604 | K-562 Blood | 1470 / 17950 (8.2%) | 6329 / 179500 (3.5%) | −163.2 | −161.2 | 2.32 |
| JADE3 DRX300415 | 293 Kidney | 1578 / 17950 (8.8%) | 7053 / 179500 (3.9%) | −162.7 | −160.7 | 2.24 |
| FOS SRX3322636 | MCF-7 Breast | 243 / 17950 (1.4%) | 9593 / 179500 (5.3%) | −162.4 | −160.4 | 0.25 |
| TP53 SRX19538282 | Osteoblasts Bone | 331 / 17950 (1.8%) | 329 / 179500 (0.2%) | −162.1 | −160.1 | 10.06 |
| TP53 SRX396254 | Fibroblasts Others | 910 / 17950 (5.1%) | 2926 / 179500 (1.6%) | −162.0 | −160.0 | 3.11 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 565 / 17950 (3.1%) | 14841 / 179500 (8.3%) | −162.0 | −160.0 | 0.38 |
| FOXL2 SRX6957431 | KGN Gonad | 927 / 17950 (5.2%) | 20072 / 179500 (11.2%) | −161.9 | −159.9 | 0.46 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 180 / 17950 (1.0%) | 8403 / 179500 (4.7%) | −161.9 | −159.9 | 0.21 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 570 / 17950 (3.2%) | 14908 / 179500 (8.3%) | −161.8 | −159.8 | 0.38 |
| ESR1 SRX371474 | BT-474 Breast | 171 / 17950 (1.0%) | 8223 / 179500 (4.6%) | −161.7 | −159.8 | 0.21 |
| FOS SRX3322637 | MCF-7 Breast | 191 / 17950 (1.1%) | 8605 / 179500 (4.8%) | −161.7 | −159.7 | 0.22 |
| ESR1 SRX1995230 | MCF-7 Breast | 321 / 17950 (1.8%) | 10926 / 179500 (6.1%) | −161.4 | −159.5 | 0.29 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 730 / 17950 (4.1%) | 17259 / 179500 (9.6%) | −161.3 | −159.3 | 0.42 |
| SUPT5H SRX2314265 | MOLT-4 Blood | 1517 / 17950 (8.5%) | 6677 / 179500 (3.7%) | −161.1 | −159.2 | 2.27 |
| KMT2B DRX059614 | HB1119 Blood | 939 / 17950 (5.2%) | 3106 / 179500 (1.7%) | −160.7 | −158.7 | 3.02 |
| AFF1 SRX15203358 | Acute lymphoid leukemia Blood | 799 / 17950 (4.5%) | 2345 / 179500 (1.3%) | −160.4 | −158.4 | 3.41 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 520 / 17950 (2.9%) | 14079 / 179500 (7.8%) | −159.9 | −158.0 | 0.37 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 303 / 17950 (1.7%) | 10572 / 179500 (5.9%) | −159.9 | −157.9 | 0.29 |
| FOXA1 SRX100454 | T-47D Breast | 540 / 17950 (3.0%) | 14382 / 179500 (8.0%) | −159.8 | −157.9 | 0.38 |
| NR3C1 SRX2609668 | HASM2 Lung | 292 / 17950 (1.6%) | 10376 / 179500 (5.8%) | −159.8 | −157.8 | 0.28 |
| NKX2-1 SRX2164786 | A549 Lung | 665 / 17950 (3.7%) | 16251 / 179500 (9.1%) | −159.8 | −157.8 | 0.41 |
| ESR1 SRX2513520 | MCF-7 Breast | 234 / 17950 (1.3%) | 9346 / 179500 (5.2%) | −159.7 | −157.8 | 0.25 |
| EP300 SRX1012648 | MCF-7 Breast | 174 / 17950 (1.0%) | 8218 / 179500 (4.6%) | −159.6 | −157.6 | 0.21 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 153 / 17950 (0.9%) | 7800 / 179500 (4.3%) | −159.4 | −157.4 | 0.20 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 182 / 17950 (1.0%) | 8360 / 179500 (4.7%) | −159.1 | −157.1 | 0.22 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 901 / 17950 (5.0%) | 2912 / 179500 (1.6%) | −159.0 | −157.1 | 3.09 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 950 / 17950 (5.3%) | 3192 / 179500 (1.8%) | −158.9 | −157.0 | 2.98 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 380 / 17950 (2.1%) | 11827 / 179500 (6.6%) | −158.9 | −156.9 | 0.32 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 291 / 17950 (1.6%) | 10323 / 179500 (5.8%) | −158.7 | −156.7 | 0.28 |
| NR3C1 SRX18884260 | A549 Lung | 217 / 17950 (1.2%) | 9001 / 179500 (5.0%) | −158.7 | −156.7 | 0.24 |
| RELA SRX5938177 | FaDu Others | 363 / 17950 (2.0%) | 11531 / 179500 (6.4%) | −158.5 | −156.6 | 0.31 |
| BRD4 SRX736204 | 90-8TL Neural | 918 / 17950 (5.1%) | 3017 / 179500 (1.7%) | −158.5 | −156.5 | 3.04 |
| FOXA1 SRX11222437 | MCF-7 Breast | 289 / 17950 (1.6%) | 10283 / 179500 (5.7%) | −158.5 | −156.5 | 0.28 |
| Epitope tags SRX11149778 | Jurkat Blood | 2287 / 17950 (12.7%) | 12193 / 179500 (6.8%) | −158.3 | −156.3 | 1.88 |
| CEBPB SRX2194249 | SUM 159PT Breast | 390 / 17950 (2.2%) | 11963 / 179500 (6.7%) | −158.2 | −156.3 | 0.33 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 284 / 17950 (1.6%) | 10179 / 179500 (5.7%) | −157.9 | −156.0 | 0.28 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 404 / 17950 (2.3%) | 12181 / 179500 (6.8%) | −157.9 | −155.9 | 0.33 |
| BRD4 SRX1637463 | MOLT-4 Blood | 2205 / 17950 (12.3%) | 11611 / 179500 (6.5%) | −157.5 | −155.5 | 1.90 |
| NR3C1 SRX10976920 | A549 Lung | 121 / 17950 (0.7%) | 7085 / 179500 (3.9%) | −157.4 | −155.4 | 0.17 |
| CEBPB SRX150598 | IMR-90 Lung | 833 / 17950 (4.6%) | 18567 / 179500 (10.3%) | −157.1 | −155.2 | 0.45 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 265 / 17950 (1.5%) | 9816 / 179500 (5.5%) | −157.1 | −155.1 | 0.27 |
| FOXA1 SRX11222441 | MCF-7 Breast | 317 / 17950 (1.8%) | 10716 / 179500 (6.0%) | −157.0 | −155.1 | 0.30 |
| EP300 SRX190219 | SK-N-SH Neural | 390 / 17950 (2.2%) | 11923 / 179500 (6.6%) | −157.0 | −155.0 | 0.33 |
| ESR1 SRX10365533 | MCF-7 Breast | 181 / 17950 (1.0%) | 8268 / 179500 (4.6%) | −156.8 | −154.8 | 0.22 |
| 8-Hydroxydeoxyguanosine SRX2935293 | MCF 10A Breast | 597 / 17950 (3.3%) | 1381 / 179500 (0.8%) | −156.8 | −154.8 | 4.32 |
| ESR1 SRX5323877 | MCF-7 Breast | 309 / 17950 (1.7%) | 10569 / 179500 (5.9%) | −156.7 | −154.8 | 0.29 |
| MAU2 SRX15710569 | RPE Neural | 380 / 17950 (2.1%) | 11732 / 179500 (6.5%) | −156.1 | −154.2 | 0.32 |
| FOXA1 SRX13814018 | 5637 Others | 245 / 17950 (1.4%) | 9427 / 179500 (5.3%) | −156.0 | −154.0 | 0.26 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 729 / 17950 (4.1%) | 17037 / 179500 (9.5%) | −155.9 | −153.9 | 0.43 |
| NR3C1 SRX18884259 | A549 Lung | 145 / 17950 (0.8%) | 7535 / 179500 (4.2%) | −155.9 | −153.9 | 0.19 |
| STAT3 SRX4192888 | MCF 10A Breast | 189 / 17950 (1.1%) | 8373 / 179500 (4.7%) | −155.2 | −153.2 | 0.23 |
| TEAD1 SRX7807114 | Unclassified Unclassified | 197 / 17950 (1.1%) | 8517 / 179500 (4.7%) | −154.9 | −153.0 | 0.23 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 378 / 17950 (2.1%) | 11655 / 179500 (6.5%) | −154.8 | −152.9 | 0.32 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 757 / 17950 (4.2%) | 17386 / 179500 (9.7%) | −154.6 | −152.7 | 0.44 |
| ESR1 SRX2513521 | MCF-7 Breast | 180 / 17950 (1.0%) | 8185 / 179500 (4.6%) | −154.6 | −152.7 | 0.22 |
| FOXA1 SRX11222442 | MCF-7 Breast | 272 / 17950 (1.5%) | 9861 / 179500 (5.5%) | −154.6 | −152.7 | 0.28 |
| AR SRX9469988 | LAPC-4 Prostate | 552 / 17950 (3.1%) | 14373 / 179500 (8.0%) | −154.5 | −152.6 | 0.38 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 515 / 17950 (2.9%) | 1037 / 179500 (0.6%) | −154.4 | −152.4 | 4.97 |
| RNF2 SRX18954719 | SCC-25 Others | 546 / 17950 (3.0%) | 14274 / 179500 (8.0%) | −154.3 | −152.4 | 0.38 |
| YAP1 SRX10119363 | MCF 10A Breast | 159 / 17950 (0.9%) | 7762 / 179500 (4.3%) | −154.1 | −152.2 | 0.20 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 322 / 17950 (1.8%) | 10692 / 179500 (6.0%) | −153.8 | −151.8 | 0.30 |
| EP300 SRX176883 | MCF-7 Breast | 178 / 17950 (1.0%) | 8115 / 179500 (4.5%) | −153.6 | −151.6 | 0.22 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 332 / 17950 (1.8%) | 10848 / 179500 (6.0%) | −153.5 | −151.6 | 0.31 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 255 / 17950 (1.4%) | 9523 / 179500 (5.3%) | −153.4 | −151.5 | 0.27 |
| STAT3 SRX8520800 | SUM 159PT Breast | 240 / 17950 (1.3%) | 9250 / 179500 (5.2%) | −153.2 | −151.2 | 0.26 |
| ESR1 SRX2943589 | MCF-7 Breast | 201 / 17950 (1.1%) | 8531 / 179500 (4.8%) | −153.0 | −151.1 | 0.24 |
| ESR1 SRX1012625 | MCF-7 Breast | 203 / 17950 (1.1%) | 8570 / 179500 (4.8%) | −153.0 | −151.0 | 0.24 |
| Epitope tags SRX15939724 | RD Muscle | 359 / 17950 (2.0%) | 11268 / 179500 (6.3%) | −152.6 | −150.7 | 0.32 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 916 / 17950 (5.1%) | 19532 / 179500 (10.9%) | −152.5 | −150.6 | 0.47 |
| MLXIP SRX5391034 | Skeletal myotubes Muscle | 507 / 17950 (2.8%) | 13610 / 179500 (7.6%) | −152.5 | −150.6 | 0.37 |
| FOXA1 SRX028634 | MCF-7 Breast | 200 / 17950 (1.1%) | 8494 / 179500 (4.7%) | −152.3 | −150.4 | 0.24 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 191 / 17950 (1.1%) | 8319 / 179500 (4.6%) | −152.1 | −150.2 | 0.23 |
| PAF1 SRX1873455 | SEM Blood | 743 / 17950 (4.1%) | 2147 / 179500 (1.2%) | −152.0 | −150.1 | 3.46 |
| DNA-RNA hybrid SRX20083261 | SH-SY5Y Neural | 592 / 17950 (3.3%) | 1402 / 179500 (0.8%) | −151.7 | −149.8 | 4.22 |
| 8-Hydroxydeoxyguanosine SRX13840522 | MCF 10A Breast | 1258 / 17950 (7.0%) | 5174 / 179500 (2.9%) | −151.6 | −149.7 | 2.43 |
| FOXA1 SRX190282 | A549 Lung | 279 / 17950 (1.6%) | 9879 / 179500 (5.5%) | −151.4 | −149.5 | 0.28 |
| Epitope tags SRX5877914 | U2OS Bone | 2271 / 17950 (12.7%) | 36706 / 179500 (20.4%) | −151.1 | −149.2 | 0.62 |
| MLLT6 DRX059637 | 293 Kidney | 416 / 17950 (2.3%) | 663 / 179500 (0.4%) | −151.1 | −149.2 | 6.27 |
| ESR1 SRX1012628 | MCF-7 Breast | 200 / 17950 (1.1%) | 8452 / 179500 (4.7%) | −150.9 | −149.0 | 0.24 |
| EP300 SRX10976541 | A549 Lung | 108 / 17950 (0.6%) | 6630 / 179500 (3.7%) | −150.9 | −149.0 | 0.16 |
| CDK9 SRX7366783 | MCF-7 Breast | 244 / 17950 (1.4%) | 144 / 179500 (0.1%) | −150.9 | −148.9 | 16.94 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 446 / 17950 (2.5%) | 12600 / 179500 (7.0%) | −150.8 | −148.9 | 0.35 |
| ESR1 SRX5534832 | MCF-7 Breast | 375 / 17950 (2.1%) | 11460 / 179500 (6.4%) | −150.6 | −148.7 | 0.33 |
| SMARCA4 SRX5982340 | A549 Lung | 150 / 17950 (0.8%) | 7480 / 179500 (4.2%) | −150.4 | −148.5 | 0.20 |
| NR3C1 SRX18884270 | A549 Lung | 171 / 17950 (1.0%) | 7879 / 179500 (4.4%) | −150.1 | −148.2 | 0.22 |
| TLE3 SRX4815193 | SUM 149PT Breast | 412 / 17950 (2.3%) | 12041 / 179500 (6.7%) | −150.1 | −148.2 | 0.34 |
| Epitope tags SRX2745846 | MCF 10A Breast | 262 / 17950 (1.5%) | 9538 / 179500 (5.3%) | −150.0 | −148.1 | 0.27 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 699 / 17950 (3.9%) | 16363 / 179500 (9.1%) | −149.7 | −147.8 | 0.43 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1131 / 17950 (6.3%) | 4408 / 179500 (2.5%) | −149.7 | −147.8 | 2.57 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 399 / 17950 (2.2%) | 11816 / 179500 (6.6%) | −149.6 | −147.7 | 0.34 |
| MED1 SRX3946904 | Mesenchymal stem cells Others | 187 / 17950 (1.0%) | 8169 / 179500 (4.6%) | −149.6 | −147.7 | 0.23 |
| Epitope tags SRX11149779 | Jurkat Blood | 2068 / 17950 (11.5%) | 10820 / 179500 (6.0%) | −149.4 | −147.5 | 1.91 |
| ESR1 SRX1012630 | MCF-7 Breast | 147 / 17950 (0.8%) | 7386 / 179500 (4.1%) | −149.4 | −147.5 | 0.20 |
| YAP1 SRX10119376 | MCF 10A Breast | 235 / 17950 (1.3%) | 9037 / 179500 (5.0%) | −149.2 | −147.3 | 0.26 |
| FOXA1 SRX3923514 | MCF-7 Breast | 437 / 17950 (2.4%) | 12402 / 179500 (6.9%) | −149.2 | −147.3 | 0.35 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 396 / 17950 (2.2%) | 11750 / 179500 (6.5%) | −149.1 | −147.2 | 0.34 |
| TLE3 SRX4815192 | MCF-7 Breast | 384 / 17950 (2.1%) | 11556 / 179500 (6.4%) | −149.1 | −147.2 | 0.33 |
| EP300 SRX1012644 | MCF-7 Breast | 179 / 17950 (1.0%) | 8002 / 179500 (4.5%) | −149.1 | −147.2 | 0.22 |
| FOXL2 SRX6957477 | KGN Gonad | 435 / 17950 (2.4%) | 12361 / 179500 (6.9%) | −148.9 | −147.0 | 0.35 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 395 / 17950 (2.2%) | 11725 / 179500 (6.5%) | −148.9 | −147.0 | 0.34 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 1695 / 17950 (9.4%) | 8166 / 179500 (4.5%) | −148.7 | −146.8 | 2.08 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 864 / 17950 (4.8%) | 2845 / 179500 (1.6%) | −148.6 | −146.7 | 3.04 |
| NR3C1 SRX10977358 | A549 Lung | 113 / 17950 (0.6%) | 6669 / 179500 (3.7%) | −148.6 | −146.7 | 0.17 |
| ESR1 SRX3110720 | MCF-7 Breast | 158 / 17950 (0.9%) | 7580 / 179500 (4.2%) | −148.5 | −146.6 | 0.21 |
| ESR1 SRX4451213 | MCF-7 Breast | 427 / 17950 (2.4%) | 12219 / 179500 (6.8%) | −148.4 | −146.5 | 0.35 |
| WWTR1 SRX10119370 | MCF 10A Breast | 242 / 17950 (1.3%) | 9130 / 179500 (5.1%) | −148.2 | −146.4 | 0.27 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 533 / 17950 (3.0%) | 1164 / 179500 (0.6%) | −148.1 | −146.2 | 4.58 |
| FOXA1 SRX1161174 | MCF-7 Breast | 450 / 17950 (2.5%) | 12566 / 179500 (7.0%) | −148.0 | −146.1 | 0.36 |
| CXXC1 SRX1424886 | SEM Blood | 1466 / 17950 (8.2%) | 6610 / 179500 (3.7%) | −147.9 | −146.1 | 2.22 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 467 / 17950 (2.6%) | 12827 / 179500 (7.1%) | −147.9 | −146.0 | 0.36 |
| FOXA1 SRX1787651 | MCF-7 Breast | 235 / 17950 (1.3%) | 8993 / 179500 (5.0%) | −147.9 | −146.0 | 0.26 |
| KMT2A SRX2281247 | SEM Blood | 1651 / 17950 (9.2%) | 7878 / 179500 (4.4%) | −147.7 | −145.9 | 2.10 |
| ARID1A SRX5089385 | MCF-7 Breast | 312 / 17950 (1.7%) | 10314 / 179500 (5.7%) | −147.4 | −145.6 | 0.30 |
| SETD1A SRX23734380 | MOLM-13 Blood | 1065 / 17950 (5.9%) | 4042 / 179500 (2.3%) | −147.3 | −145.4 | 2.63 |
| RELA SRX7054617 | HAEC Cardiovascular | 507 / 17950 (2.8%) | 13419 / 179500 (7.5%) | −147.3 | −145.4 | 0.38 |
| BRD4 SRX369136 | CUTLL1 Blood | 1453 / 17950 (8.1%) | 6543 / 179500 (3.6%) | −146.9 | −145.0 | 2.22 |
| DDIT3 SRX11379509 | Liposarcoma, Myxoid Adipocyte | 316 / 17950 (1.8%) | 10353 / 179500 (5.8%) | −146.6 | −144.8 | 0.31 |
| FOXA1 SRX1787655 | MCF-7 Breast | 204 / 17950 (1.1%) | 8387 / 179500 (4.7%) | −146.5 | −144.6 | 0.24 |
| FOXA2 SRX100448 | Hep G2 Liver | 485 / 17950 (2.7%) | 13054 / 179500 (7.3%) | −146.4 | −144.5 | 0.37 |
| RELA SRX7055007 | HAEC Cardiovascular | 769 / 17950 (4.3%) | 17230 / 179500 (9.6%) | −146.4 | −144.5 | 0.45 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1248 / 17950 (7.0%) | 23722 / 179500 (13.2%) | −146.4 | −144.5 | 0.53 |
| 8-Hydroxydeoxyguanosine SRX13840520 | MCF 10A Breast | 897 / 17950 (5.0%) | 3065 / 179500 (1.7%) | −146.2 | −144.3 | 2.93 |
| ESR1 SRX5534831 | MCF-7 Breast | 321 / 17950 (1.8%) | 10420 / 179500 (5.8%) | −146.1 | −144.2 | 0.31 |
| FOXA1 SRX028635 | MCF-7 Breast | 209 / 17950 (1.2%) | 8464 / 179500 (4.7%) | −146.0 | −144.1 | 0.25 |
| CEBPB SRX7807101 | Unclassified Unclassified | 311 / 17950 (1.7%) | 10248 / 179500 (5.7%) | −145.9 | −144.1 | 0.30 |
| CREBBP SRX7214025 | Keratinocytes Epidermis | 247 / 17950 (1.4%) | 9140 / 179500 (5.1%) | −145.8 | −143.9 | 0.27 |
| ESR1 SRX5089447 | MCF-7 Breast | 184 / 17950 (1.0%) | 7995 / 179500 (4.5%) | −145.8 | −143.9 | 0.23 |
| GFP SRX6949256 | HeLa Uterus | 467 / 17950 (2.6%) | 12754 / 179500 (7.1%) | −145.8 | −143.9 | 0.37 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 514 / 17950 (2.9%) | 13473 / 179500 (7.5%) | −145.8 | −143.9 | 0.38 |
| FOXA1 SRX1787652 | MCF-7 Breast | 258 / 17950 (1.4%) | 9334 / 179500 (5.2%) | −145.7 | −143.8 | 0.28 |
| YAP1 SRX10119375 | MCF 10A Breast | 255 / 17950 (1.4%) | 9281 / 179500 (5.2%) | −145.7 | −143.8 | 0.27 |
| NFYB SRX16608147 | HeLa Uterus | 262 / 17950 (1.5%) | 201 / 179500 (0.1%) | −145.6 | −143.7 | 13.03 |
| BRD4 SRX448939 | KOPT-K1 Blood | 1221 / 17950 (6.8%) | 5049 / 179500 (2.8%) | −145.4 | −143.6 | 2.42 |
| Epitope tags SRX11149772 | Jurkat Blood | 2413 / 17950 (13.4%) | 13520 / 179500 (7.5%) | −145.4 | −143.6 | 1.78 |
| NR3C1 SRX1672123 | BEAS-2B Lung | 275 / 17950 (1.5%) | 9614 / 179500 (5.4%) | −145.3 | −143.4 | 0.29 |
| MITF SRX7368256 | Hermes 3C Epidermis | 839 / 17950 (4.7%) | 18162 / 179500 (10.1%) | −145.2 | −143.3 | 0.46 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 659 / 17950 (3.7%) | 15601 / 179500 (8.7%) | −145.1 | −143.3 | 0.42 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 311 / 17950 (1.7%) | 10214 / 179500 (5.7%) | −144.9 | −143.1 | 0.30 |
| NR3C1 SRX18884253 | A549 Lung | 155 / 17950 (0.9%) | 7410 / 179500 (4.1%) | −144.9 | −143.0 | 0.21 |
| NR3C1 SRX10976391 | A549 Lung | 107 / 17950 (0.6%) | 6426 / 179500 (3.6%) | −144.6 | −142.8 | 0.17 |
| BRD4 SRX327752 | U-87 MG Neural | 763 / 17950 (4.3%) | 17070 / 179500 (9.5%) | −144.5 | −142.7 | 0.45 |
| SMARCA2 SRX5982361 | A549 Lung | 124 / 17950 (0.7%) | 6780 / 179500 (3.8%) | −144.5 | −142.7 | 0.18 |
| NR3C1 SRX19024866 | MCF-7 Breast | 139 / 17950 (0.8%) | 7082 / 179500 (3.9%) | −144.5 | −142.6 | 0.20 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 405 / 17950 (2.3%) | 11732 / 179500 (6.5%) | −144.5 | −142.6 | 0.35 |
| MCM7 SRX8970972 | Squamous cell carcinoma Others | 479 / 17950 (2.7%) | 12889 / 179500 (7.2%) | −144.4 | −142.6 | 0.37 |
| FOXA1 SRX1447317 | MCF-7 Breast | 279 / 17950 (1.6%) | 9655 / 179500 (5.4%) | −144.4 | −142.6 | 0.29 |
| Epitope tags SRX10549777 | K-562 Blood | 2461 / 17950 (13.7%) | 13921 / 179500 (7.8%) | −144.4 | −142.6 | 1.77 |
| CEBPB SRX7807103 | Adipocytes Adipocyte | 394 / 17950 (2.2%) | 11554 / 179500 (6.4%) | −144.4 | −142.6 | 0.34 |
| CDK9 SRX7366781 | MCF-7 Breast | 233 / 17950 (1.3%) | 137 / 179500 (0.1%) | −144.3 | −142.4 | 17.01 |
| ESR1 SRX1469950 | MCF-7 Breast | 143 / 17950 (0.8%) | 7152 / 179500 (4.0%) | −144.0 | −142.2 | 0.20 |
| FOXA1 SRX5323843 | MCF-7 Breast | 223 / 17950 (1.2%) | 8648 / 179500 (4.8%) | −143.8 | −141.9 | 0.26 |
| TEAD4 SRX190314 | SK-N-SH Neural | 207 / 17950 (1.2%) | 8350 / 179500 (4.7%) | −143.5 | −141.6 | 0.25 |
| ESR1 SRX2513519 | MCF-7 Breast | 224 / 17950 (1.2%) | 8655 / 179500 (4.8%) | −143.4 | −141.6 | 0.26 |
| SMARCA4 SRX5982364 | A549 Lung | 123 / 17950 (0.7%) | 6729 / 179500 (3.7%) | −143.4 | −141.5 | 0.18 |
| FOXA1 SRX100506 | Hep G2 Liver | 582 / 17950 (3.2%) | 14403 / 179500 (8.0%) | −143.4 | −141.5 | 0.40 |
| HDAC1 SRX17989500 | PBMC Blood | 1588 / 17950 (8.8%) | 7543 / 179500 (4.2%) | −143.4 | −141.5 | 2.11 |
| ESR1 SRX176856 | MCF-7 Breast | 138 / 17950 (0.8%) | 7031 / 179500 (3.9%) | −143.4 | −141.5 | 0.20 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 556 / 17950 (3.1%) | 14010 / 179500 (7.8%) | −143.1 | −141.3 | 0.40 |
| RBFOX2 SRX4708082 | K-562 Blood | 2372 / 17950 (13.2%) | 13280 / 179500 (7.4%) | −143.0 | −141.2 | 1.79 |
| JUN SRX2355073 | HAEC Cardiovascular | 544 / 17950 (3.0%) | 13819 / 179500 (7.7%) | −143.0 | −141.1 | 0.39 |
| HOXC5 SRX2731653 | PC-3 Prostate | 343 / 17950 (1.9%) | 10674 / 179500 (5.9%) | −142.8 | −141.0 | 0.32 |
| FOXA2 SRX3230382 | Hep G2 Liver | 596 / 17950 (3.3%) | 14586 / 179500 (8.1%) | −142.8 | −140.9 | 0.41 |
| JUN SRX150358 | HUVEC Cardiovascular | 278 / 17950 (1.5%) | 9580 / 179500 (5.3%) | −142.8 | −140.9 | 0.29 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 317 / 17950 (1.8%) | 10233 / 179500 (5.7%) | −142.6 | −140.7 | 0.31 |
| YAP1 SRX5887611 | PC-9 Lung | 226 / 17950 (1.3%) | 8662 / 179500 (4.8%) | −142.4 | −140.6 | 0.26 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 579 / 17950 (3.2%) | 14318 / 179500 (8.0%) | −142.3 | −140.5 | 0.40 |
| GFP SRX5417098 | HeLa Uterus | 502 / 17950 (2.8%) | 13163 / 179500 (7.3%) | −142.3 | −140.5 | 0.38 |
Showing first 500 of 19316 rows.